Security key
457669307
INSMED Inc - Common Stock, par value $0.01 per share (INSM)
CUSIP: 457669307
Q1 2017 13F Holders as of 31 Mar 2017
- Security type / class
- Equity / Common Stock, par value $0.01 per share
- Total 13F shares
- 56,998,661
- Total 13F value
- $998,026,125
- Share change
- +3,748,192
- Put/Call ratio
- 554%
- SEC-reported price per share
- $17.51
- Number of holders
- 97
- Value change
- +$70,030,475
- Number of buys
- 46
- Number of sells
- 45
- Shares outstanding
- 215,451,077
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2017
Institutions
97
Top holders
10
INSM full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2017
Previous quarter: Q4 2016
INSMED Inc SEC filings
INSMED Inc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 457669307
Recent filing periods:
Ownership snapshot
Top reported holders of INSM - INSMED Inc - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PRICE T ROWE ASSOCIATES I...
Disclosed value leader
PRICE T ROWE ASSOCIATES I...
Comparable rows
15/15
Latest evidence
31 Dec 2016
13F
Lead comparable stake: 4.9%
Showing 1-6 of 15 holder rows.
Quick read
PRICE T ROWE ASSOCIATES INC /MD/ leads the comparable SEC ownership view at 4.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PRICE T ROWE ASSOCIATES INC /MD/'s linked filing trail.
Comparable ownership
Top 5
PRICE T ROWE ASSOCIATES INC /MD/
4.9%
FMR LLC
4.3%
Palo Alto Investors LP
2.5%
ORBIMED ADVISORS LLC
2.5%
VANGUARD GROUP INC
1.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
4.9%
|
$139,007,000
10,506,925 shares
|
— | 31 Dec 2016 |
| FMR LLC |
13F
Company
|
4.3%
|
$122,796,000
9,281,685 shares
|
— | 31 Dec 2016 |
| Palo Alto Investors LP |
13F
Company
|
2.5%
|
$72,057,000
5,446,516 shares
|
— | 31 Dec 2016 |
| ORBIMED ADVISORS LLC |
13F
Company
|
2.5%
|
$70,143,000
5,301,805 shares
|
— | 31 Dec 2016 |
| VANGUARD GROUP INC |
13F
Company
|
1.7%
|
$47,734,000
3,607,951 shares
|
— | 31 Dec 2016 |
| JANUS HENDERSON INVESTORS US LLC |
13F
Company
|
1.3%
|
$37,784,000
2,855,576 shares
|
— | 31 Dec 2016 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2017
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
97
Shares
56,998,661
Rows available
97
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2017 vs Q4 2016 Across Filers
Q4 2016 holders
96
Q1 2017 holders
97
Holder diff
1
| Investor | Q4 2016 Shares | Q1 2017 Shares | Share Diff | Share Chg % | Q4 2016 value | Q1 2017 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend